GPT and metabolic syndrome: The chi-square comparison also showed that female participants with ALT levels >36 U/L had a tendency towards a higher prevalence of MetS (88.9% vs. 61.1%, p = 0.001) compared with the prevalence of those with ALT levels ≤36 U/L (Figure 2(b)).